Chapter 7 - Ethical issues in research and development of nanoparticles

dc.commentsCEB53630por
dc.contributor.authorSouto, Eliana B.por
dc.contributor.authorDias-Ferreira, Joãopor
dc.contributor.authorShegokar, Ranjitapor
dc.contributor.authorDurazzo, Alessandrapor
dc.contributor.authorSantini, Antonellopor
dc.date.accessioned2021-10-11T09:45:48Z
dc.date.embargo10000-01-01
dc.date.issued2020
dc.date.updated2021-10-10T10:28:27Z
dc.description.abstractCurrent societal challenges demonstrate the added value of nanotechnology in improving several goods in a set of industries (e.g., pharmaceuticals, nutraceuticals, cosmetics, medical devices). Along with the unprecedent technological developments, ethical issues are posed to scientists, regulators, and users as new materials with new functionalities are being launched that have unforeseen impact in the society. The transformation of a bulk material into its nanosized counterpart requires serious follow-up as the obtained nanomaterial will have a distinct reactivity both in vitro and in vivo. Indeed, depending on the type of nanoparticles (i.e., their shape, size, morphology, surface properties, and concentration), they will interact with the biological surroundings interfering with cellular processes and resulting in increased risk of toxicological events. This chapter addresses the ethical issues encountered with the application of nanotechnology in the development of new materials to be used in health care, together with the socioeconomic and environmental impact.por
dc.description.publicationversioninfo:eu-repo/semantics/publishedVersion
dc.description.sponsorshipThis work was partly financed through the projects M-ERA-NET/0004/2015-PAIRED and UIDB/04469/2020. It received support from the Portuguese Science and Technology Foundation, Ministry of Science and Education (FCT/MEC) through national funds, and was also co-financed by FEDER, under the Partnership Agreement PT2020.por
dc.distributioninternational
dc.identifier.citationSouto, Eliana; Dias-Ferreira, João; Shegokar, Ranjita; Durazzo, Alessandra; Santini, Antonello, Chapter 7 - Ethical issues in research and development of nanoparticles. In Ranjita Shegokar, Drug Delivery Aspects Volume 4: Expectations and Realities of Multifunctional Drug Delivery Systems, Elsevier, 2020. ISBN: 978-0-12-821222-6, 157-168por
dc.identifier.doi10.1016/B978-0-12-821222-6.00007-5por
dc.identifier.isbn978-0-12-821222-6por
dc.identifier.urihttps://hdl.handle.net/1822/74298
dc.language.isoengpor
dc.peerreviewedyes
dc.publisherElsevierpor
dc.relationUIDB/04469/2020por
dc.relation.publisherversionhttps://www.sciencedirect.com/book/9780128212226/drug-delivery-aspectspor
dc.rightsrestrictedAccesspor
dc.subjectEthical issuespor
dc.subjectNanoparticlespor
dc.subjectNanotechnologypor
dc.subjectPharmaceuticalspor
dc.subjectNutraceuticalspor
dc.subject.fosCiências Naturais::Ciências Biológicaspor
dc.titleChapter 7 - Ethical issues in research and development of nanoparticlespor
dc.typebookPartpor
dspace.entity.typePublicationen
oaire.citationEndPage168por
oaire.citationStartPage157por
sdum.bookTitleDrug Delivery Aspects Volume 4: Expectations and Realities of Multifunctional Drug Delivery Systemspor

Ficheiros

Pacote original

A mostrar 1 - 1 de 1
A carregar...
Nome:
document_53630_1.pdf
Tamanho:
208.09 KB
Formato:
Adobe Portable Document Format